Cells for Cells Competitors and Similar CompaniesClear all
Cells for Cells's competitors and similar companies include InGeneron, Sea4Us, Crinetics Pharmaceuticals and Genexine.
 Cells for Cells Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies. |  InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  Sea4Us Sea4Us is a biopharmaceutical company focused on the discovery and development of pharmaceutical drugs based on marine compounds. |  Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. |  Genexine Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics. | |
Founding Date | Founding Date 2010 | Founding Date 2006 | Founding Date 2013 | Founding Date 2008 | Founding Date 1999 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Las Condes, CL HQ | Locations Houston, US HQ München, DE | Locations Budens, PT HQ | Locations San Diego, US HQ | Locations Seongnam-si, KR HQ New York, US |
Employees | Employees 264% increase | Employees 16 | Employees 23 | Employees 43751% increase | Employees 86 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) ₩4.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $1.1m (FY, 2025) | Cost of goods (₩503.7m) (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $6.6m (FY, 2025) | Gross profit ₩7.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($465.3m) (FY, 2025) | Net income (₩27.2b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 47.5m | Total funding raised N/A | Total funding raised $ 41.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
InGeneron
HQ
Houston, US
Employees
16
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
View companySea4Us
HQ
Budens, PT
Employees
23
Sea4Us is a biopharmaceutical company focused on the discovery and development of pharmaceutical drugs based on marine compounds.
View companyCrinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View companyGenexine
HQ
Seongnam-si, KR
Employees
86
Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics.
View company